<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Patients with <z:hpo ids='HP_0001417'>X-linked</z:hpo> lymphoproliferative (XLP) disease are characterized by extreme vulnerability to Epstein-Barr virus (EBV) </plain></SENT>
<SENT sid="1" pm="."><plain>Following <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> with EBV, affected males develop <z:e sem="disease" ids="C1264624" disease_type="Disease or Syndrome" abbrv="">fatal infectious mononucleosis</z:e> (IM), <z:hpo ids='HP_0004313'>hypogammaglobulinemia</z:hpo> (H), or non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL) </plain></SENT>
<SENT sid="2" pm="."><plain>In addition, hyper IgM, red cell <z:mpath ids='MPATH_58'>aplasia</z:mpath>, necrotizing lymphoid <z:hpo ids='HP_0002633'>vasculitis</z:hpo> (NLV), and <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> occur rarely </plain></SENT>
<SENT sid="3" pm="."><plain>The recent use of DNA restriction fragment length polymorphism (RFLP) probes in linkage with the XLP gene now permit detection of affected males prior to primary <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>We have measured immunoglobulin class and subclass levels in sera from EBV-negative males who were either positive or negative for the XLP genotype by RFLP analysis </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0003261'>Elevated IgA</z:hpo> or IgM and/or variable deficiency of IgG, IgG1, and IgG3 occurred in the sera of 13/13 RFLP-positive, EBV-negative males </plain></SENT>
<SENT sid="6" pm="."><plain>No consistent abnormalities were noted in 14 RFLP-negative, EBV-negative males </plain></SENT>
<SENT sid="7" pm="."><plain>We conclude that the immune defect in XLP is not solely EBV-specific, although EBV is responsible for most of the morbidity and <z:hpo ids='HP_0000001'>all</z:hpo> of the mortality </plain></SENT>
<SENT sid="8" pm="."><plain>Further, serial measurement of Ig levels may provide information regarding status of EBV-negative males at risk where RFLP analysis is uninformative or in families where <z:hpo ids='HP_0003745'>sporadic</z:hpo> cases of fatal IM, acquired <z:hpo ids='HP_0004313'>hypogammaglobulinemia</z:hpo> or NHL have occurred, but wherein the genotype of XLP cannot be documented </plain></SENT>
</text></document>